On January 24th, the Center for Drug Evaluation of the National Medical Products Administration released a correction statement, aiming at the problem of data duplication existing in individual varieties publicly disclosed on the website of the Center for Drug Evaluation of the National Medical Products Administration. After verification, it was due to editing errors when disclosing relevant product information in 2019 and 2021. The wrong information has been corrected on the center's website as soon as possible. The details of the statement are as follows:

Recently, the Center for Drug Evaluation of the National Medical Products Administration received reports from relevant media and enterprises that there were problems of data duplication in individual varieties publicly disclosed on the website of the Center for Drug Evaluation of the National Medical Products Administration.

The Center for Drug Evaluation of the National Medical Products Administration immediately verified the data of relevant varieties. After verification, it was due to editing errors when disclosing relevant product information in 2019 and 2021. The center has corrected the wrong information on the website at the first time.

For the mistakes occurred in the work, the Center for Drug Evaluation of the National Medical Products Administration expresses deep apologies. It will strengthen the review of public information in the future to avoid the recurrence of similar problems. Welcome the supervision from all walks of life!

Source: https://finance.eastmoney.com/a/202501263308290529.html